Zymeworks reviews

- Ineffective, clueless upper management and board of directors. It has been obvious to the people in the trenches for several years that the company has been overextending itself and spending too much money. - No raises and bonuses for 2021 and none for the foreseeable future. - The company is losing critical employees at a head-spinning rate. Upper management seems unconcerned and has not taken action to prevent this. - It is unfathomable that the former CFO was promoted to COO and remains part of the leadership team given the company's financial situation. - A joke of a retention plan. Only slightly less insulting than receiving a gift card from IHOP.

Company mismanagement of programs, employee hiring, and funds led to catastrophically unsustainable financial situation during the latest biotech stock downturn. The original executive leadership essentially could not effectively strategize the company's research & development efforts in an effective manner. Combined with unsustainable hiring without any checks resulted in a massive restructuring that was triggered by overhaul of the CEO and some other executive members. The worst part is that the employees paid for the mistakes of executive leadership made over the past decade, and were punished for their hard work by mass layoffs, bonuses cancelled, pay raises/promotions cancelled, etc.